With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...

in line with other drugs used to treat rare, chronic diseases. The approval will give Sanofi its first opportunity get a return on its investment in Bioverativ, a company it acquired for $11.6 ...

Florian Häse, Research Scientist, Bayer What Bayer Does: Best known as the creator of aspirin, today it’s one of the largest companies in the world, with core competencies in the life science fields ...

AI-biologics vs. AI-small molecule discovery spaces Compared to the small molecule AI drug discovery ecosystem, this space is evolving differently. ‘Closed-loop’ companies that bring the best ...